Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Thu, 15 Jan 2026 12:42:00 -0500

Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched" or the "Company"), a life sciences company dedicated to developing and commercializing products derived from the Amanita Muscaria mushroom, is pleased to announce a key commercial milestone for its newest product, Calmer. The Company has officially sold out of its initial production run following strong early demand and positive consumer feedback.

Newest Product: Calmer

To view an enhanced version of this graphic, please visit:

Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Thu, 15 Jan 2026 12:42:00 -0500

Newest Product: Calmer

To view an enhanced version of this graphic, please visit:

Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm

Thu, 27 Nov 2025 07:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offering that delivers twice the potency of its flagship product, Calm.

The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers

Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm

Thu, 27 Nov 2025 07:30:00 -0500

Psyched Wellness Provides Comprehensive Investor Update

Thu, 09 Oct 2025 07:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide the following corporate update to its investors.

Product Development & Launches

Santa - Dietary Supplement Shot

Following the initial pilot run announced on April 10, 2025, the Company has made significant progress on its new dietary supplement shot, Santa.

On September 15, 2025, the Company completed an initial production run in preparation for a soft launch on October

Psyched Wellness Provides Comprehensive Investor Update

Thu, 09 Oct 2025 07:30:00 -0500

Product Development & Launches

Santa - Dietary Supplement Shot

Following the initial pilot run announced on April 10, 2025, the Company has made significant progress on its new dietary supplement shot, Santa.

On September 15, 2025, the Company completed an initial production run in preparation for a soft launch on October

Psyched Wellness Provides Comprehensive Investor Update

Thu, 10 Apr 2025 07:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to announce that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of our new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback

Psyched Wellness Provides Comprehensive Investor Update

Thu, 10 Apr 2025 07:30:00 -0500

Psyched Wellness Provides Comprehensive Investor Update

Fri, 14 Mar 2025 07:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - March 14, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide a corporate update to its shareholders.

Recent Developments

In August 2020, KGK Science ("KGK"), a licensed CRO in Canada, completed a GAP analysis and Path to Market for Psyched's flagship product as a health supplement. Throughout the fall of 2024 and into 2025, Psyched engaged various industry and regulatory experts to conduct a comprehensive review of

Psyched Wellness Provides Comprehensive Investor Update

Fri, 14 Mar 2025 07:30:00 -0500

Recent Developments

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Mon, 25 Nov 2024 07:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom announces today that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024. The Company is pleased to announce that Trevor Mayer has been appointed as a replacement nominee director of Gotham Green effective November 22, 2024. The Company would like to thank Mr.

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Mon, 25 Nov 2024 07:30:00 -0500

Psyched Wellness Announces Supply Chain Disruption in the US

Tue, 06 Aug 2024 16:44:00 -0500

Toronto, Ontario--(Newsfile Corp. - August 6, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched"), a life sciences company focused on the production and distribution of health and wellness products, announces that on July 27th, 2024, it was notified of a supply chain disruption at its sole manufacturing facility in the United States. The facility is operated by a third-party contractor and is used by Psyched to produce its proprietary extracts AME-1 and Calm.

Psyched has an existing inventory of products, and consequently the Board and management have determined that online sales will be suspended until such

Psyched Wellness Announces Supply Chain Disruption in the US

Tue, 06 Aug 2024 16:44:00 -0500

Psyched has an existing inventory of products, and consequently the Board and management have determined that online sales will be suspended until such

Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer

Wed, 17 Jul 2024 09:10:00 -0500

Toronto, Ontario--(Newsfile Corp. - July 17, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to update the markets with the latest list of specialty retailers that have signed on to sell Calm.

In addition to the previously announced retail partners, Erewhon, Central Markets, Good Earth Markets, and Market of Choice, we are pleased to share that Calm will be available at Harmons locations in the United States.

Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer

Wed, 17 Jul 2024 09:10:00 -0500

Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA

Thu, 13 Jun 2024 07:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - June 13, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to announce it will be releasing a new product this summer - Amanita Muscaria watermelon Gummies.

By using the Company's proprietary extract (AME-1) in the formulation, we have created the first and only legal and safe for human consumption Amanita Muscaria gummies in the United States of America.

The gummies will be called "Fly (Agaric)" and are

Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA

Thu, 13 Jun 2024 07:30:00 -0500

The gummies will be called "Fly (Agaric)" and are

StreetInsider.com News Articles

Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm

Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm

Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Provides Comprehensive Investor Update

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Psyched Wellness Announces Supply Chain Disruption in the US

Psyched Wellness Announces Supply Chain Disruption in the US

Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer

Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer

Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA

Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA